Eligi
Med
Ensayos clínicos
Suscripción
Sobre EligiMed
Ensayos Clínicos de Enfermedades Infecciosas | EligiMed
Ensayos clínicos
8.676 ensayos encontrados
Completado
Fase 3
ClinicalTrials.gov
A Multicenter, Randomized, Observer-Blinded, Active-Controlled Study to Evaluate the Safety, Tolerability, Efficacy, and Pharmacokinetics of Ceftaroline Versus Comparator in Pediatric Subjects With Acute Bacterial Skin and Skin Structure Infections
INTERVENTIONAL
Inicio: 1 de dic de 2011
ID: NCT01400867
Completado
Fase 2
ClinicalTrials.gov
A Phase 2, Open-Label Study of Daclatasvir (BMS-790052) and TMC435 in Combination With or Without Ribavirin (RBV) For Treatment-Naive Subjects or Null Responders to Prior Peginterferon Alfa (PegIFN)/RBV Therapy With Genotype 1 Chronic Hepatitis C
INTERVENTIONAL
Inicio: 1 de jul de 2012
ID: NCT01628692
Completado
Fase 3
ClinicalTrials.gov
A Phase III, Randomized, Double-Blind Placebo-Controlled, Multicenter Study To Evaluate the Efficacy and Safety of Baloxavir Marboxil in Combination With Standard-of-Care Neuraminidase Inhibitor in Hospitalized Participants With Severe Influenza
INTERVENTIONAL
Inicio: 8 de ene de 2019
ID: NCT03684044
Terminado
Fase 3
ClinicalTrials.gov
Randomized, Double-blind, Placebo-controlled Trial of TAF/FTC for Pre-exposure Prophylaxis of COVID-19 in Healthcare Workers (CoviPrep Study)
INTERVENTIONAL
Inicio: 31 de jul de 2020
ID: NCT04405271
Completado
Fase 3
ClinicalTrials.gov
The Intensive Pharmacokinetics Sub-study of Encore1: A Randomised, Double-blind, Placebo-controlled, Clinical Trial to Compare the Safety and Efficacy of Reduced Dose Efavirenz (EFV) With Standard Dose EFV Plus Two Nucleotide Reverse Transcriptase Inhibitors (N(t)RTI) in Antiretroviral-naïve HIV-infected Individuals Over 96 Weeks
INTERVENTIONAL
Inicio: 1 de sept de 2011
ID: NCT01271894
Completado
Fase 4
ClinicalTrials.gov
Maraviroc Switch Collaborative Study Renal Substudy
INTERVENTIONAL
Inicio: 1 de jun de 2012
ID: NCT01637259
Completado
Fase 2
ClinicalTrials.gov
A Phase II, Open Label Trial, to Evaluate Pharmacokinetics, Safety, Tolerability and Antiviral Activity of DRV in Combination With Low-Dose Ritonavir (DRV/Rtv) in Treatment-Experienced HIV-1 Infected Children From 3 Years to Below 6 Years of Age
INTERVENTIONAL
Inicio: 1 de sept de 2009
ID: NCT00919854
Anterior
1
...
44
45
46
...
434
Siguiente
Filtros